Penumbra, Inc. (NYSE:PEN) Q3 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, good afternoon. My name is Abby, and I'll be your conference operator today.
Penumbra Inc (PEN)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 970,998 | $245,973,213 | +344% | 0.04% |
| 2. | Holocene Advisors Brandon Haley | 310,219 | $78,584,677 | 0.18% | |
| 3. | AQR Capital Management Cliff Asness | 234,455 | $59,392,087 | -30% | 0.04% |
| 4. | Millennium Management Israel Englander | 233,306 | $59,101,076 | +243% | 0.03% |
| 5. | Perceptive Advisors Joseph Edelman | 220,547 | $55,868,966 | +573% | 1.61% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $156.40 | 700 | $109,480.00 | 3,850 | 2018-05-25 | Filing | |
| $25.50 | 1,538 | $39,219.00 | 2,538 | 2016-05-19 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $298.02 | 10 | $2,980.20 | 64,136 | 2025-12-01 | Filing | |
| $297.50 | 78 | $23,205.00 | 64,146 | 2025-12-01 | Filing | |
| $296.27 | 80 | $23,701.60 | 64,224 | 2025-12-01 | Filing | |
| $295.38 | 144 | $42,534.72 | 64,304 | 2025-12-01 | Filing | |
| $294.52 | 155 | $45,650.60 | 64,448 | 2025-12-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,891,665 | $1,492,476,488 | 0.08% | |
| 2. | 4,170,892 | $1,056,570,361 | 0.02% | |
| 3. | 3,835,483 | $971,604,553 | 0.01% | |
| 4. | 1,164,950 | $295,105,134 | 0.01% | |
| 5. | 908,546 | $230,152,873 | 0.17% |
News See All
Needham Upgrades Penumbra (PEN) to Buy Amid 2026 Growth Outlook
Penumbra, Inc. (NYSE:PEN) ranks among the best medical device stocks to invest in. Needham raised Penumbra, Inc.
12 Best Medical Device Stocks to Invest In Now
As chronic diseases like diabetes and cancer become more common, medical device technology is becoming increasingly innovative.
12 Best Healthcare Stocks to Buy and Hold for 5 Years
Most Americans have endured the annoyance of having their health insurance denied, frequently with no resolution even after contacting carriers via phone and email. This can be changed by Dr.
What Makes Penumbra (PEN) a Good Investment?
ClearBridge Investments, an investment management company, released its “ClearBridge Select Strategy” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. U.S.
Penumbra, Inc. (PEN): A Bull Case Theory
We came across a bullish thesis on Penumbra, Inc. on Stock Analysis Compilation’s Substack. In this article, we will summarize the bulls’ thesis on PENz.
Should You Invest in Penumbra (PEN)?
Baron Funds, an investment management company, released its “Baron Health Care Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Penumbra, Inc. (NYSE:PEN) Q2 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, good afternoon. My name is Abby, and I'll be your conference operator today.
Penumbra (PEN) Announces Completion of Enrollment in STORM-PE Clinical Trial
Penumbra, Inc. (NYSE:PEN) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds. The company announced the completion of enrollment in STORM-PE clinical trial.